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Renal morphology in essential hypertension: Analysis of 1177
unselected cases. Morphological and clinical analysis of 1177
renal biopsies from nonselected patients with essential hyperten-
sion revealed compensated benign nephrosclerosis in 775 cases.
Decompensated benign nephrosclerosis was found in 251 cases,
and secondary malignant nephrosclerosis was found in 151 cases.
This article describes the morphological and clinical features of
decompensated benign nephrosclerosis, which has received little
recognition until now. The morphological and clinical features of
secondary malignant nephrosclerosis, which is induced by hyper-
tension, are also considered. There is also a discussion of the
differentiation of the latter from primary malignant nephroscle-
rosis, in which stenosis of the preglomerular vessels develops in
the presence of normal blood pressure and leads secondarily to
renal hypertension.
A morphological and clinical analysis of 1177 renal
biopsies from nonselected patients with essential hyperten-
sion yielded the following results.
In most cases (N 5 775), kidneys showed only the
changes of compensated benign nephrosclerosis (BN), with
varying degrees of segmental arteriolar hyalinosis, some-
times associated with ischemic glomerulopathy. These
cases had a mean blood pressure (BP) of 181/109 6 38/22
mm Hg (systolic/diastolic 6 SD). The mean serum creati-
nine concentration was 1.3 6 0.6 mg%. This value was too
high, considering that in an unknown number of these
patients with essential hypertension, mild acute renal fail-
ure developed with serum creatinine values up to 2.8 mg%
[1] as a consequence of BP reduction before the diagnostic
biopsy. The area of the juxtaglomerular apparatus (JGA) as
the location for renin production was, as shown by mor-
phometric investigations [2], equivalent to kidneys in pa-
tients with normal BP.
Decompensated benign nephrosclerosis (DBN) was ob-
served in 251 cases. Fahr first described this condition in
1925 [3] and 1934 [4], and we later rediscovered it [5].
According to our investigations, DBN leads, in contrast to
the compensated form, to chronic renal failure within a few
years (five-year renal survival rate 35.9%, 10-year renal
survival rate 23.6% [6]). The preglomerular arterioles
showed a lesser degree of hyalinosis and sclerosis in
morphometric investigations [7], although average BP of
198/116 6 32/18 mm Hg was significantly higher than in the
compensated form. The mean serum creatinine concentra-
tion (3.8 6 3.1 mg%) was significantly higher in DBN than
in the compensated form. In addition, there was protein-
uria of 2.6 6 2.5 g/day. The JGA was clearly atrophic in
DBN. DBN afflicted mainly males. The male to female
ratio was 5.5:1. The compensated form occured slightly
more frequently in men than in women with a male to
female ratio of 1.6:1. Patients with BN and DBN were
approximately the same age, that is, 43 6 12 and 46 6 13
years, respectively.
We believe that DBN is thus a separate disease entity
with its own characteristic clinical picture and that it is
incorrectly included under focal sclerosing glomerulone-
phritis in the literature [8] and thus has not been recog-
nized. DBN differed histologically from the compensated
form by the occurrence of focal and segmental glomerulo-
sclerosis with subendothelial hyalinosis. This corresponded
in detail to the so-called hyperperfusion lesions in the rat
described by Nagata et al and Kriz et al [9, 10]. In addition,
DBN was characterized by the development of a variable
degree of interstitial fibrosis with obliteration of the post-
glomerular capillaries. Changes in DBN began in the
juxtamedullary glomeruli, which did not autoregulate, and
proceeded from there to the cortex. DBN is almost un-
known because it is confused with focal sclerosing glomer-
ulonephritis, which is in our opinion a complication of
minimal change disease. In cases of focal sclerosing glo-
merulonephritis, 30% of which were associated with mod-
erate hypertension (mean BP of 143/87 mm Hg [11]), the
podocyte foot processes were always effaced, but in DBN,
they were intact, even in the rare cases in which severe
proteinuria with incomplete nephrotic syndrome occurs.
Secondary malignant nephrosclerosis (SMN) was found
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in 151 cases [12]. The interlobular arteries exhibited sub-
endothelial edema in the early stages of this condition and
subendothelial fibrosis in advanced disease. The stenotic
lesions developed secondary to malignant hypertension
(mean BP 228/132 mm Hg) with consecutive overstretching
of the vascular walls and development of gaps between the
endothelial cells. The serum creatinine concentration was
highest in this condition (mean 6.6 6 5.4 mg%) and
proteinuria moderate (mean 2.1 6 2.3 g/day). The male to
female ratio was 2.5:1, and the mean age at time of renal
biopsy was 40 6 11 years.
The JGA was enlarged in SMN compared with normal
kidneys [2]; this was associated with an increased renin
production during the course of this disease: the original
“red hypertension,” as described by Volhard, turned to
“white hypertension.”
Secondary malignant nephrosclerosis, as a consequence
of severe hypertension, must be distinguished from primary
malignant nephrosclerosis [13] in which the stenotic lesions
develop in the presence of normal BP as a result of toxic
endothelial cell damage in hemolytic-uremic syndrome.
The discrepancy with regard to the prognosis of essential
hypertension between our findings (34.1%) and those in
the American literature (10% to 28%) [14] may be ex-
plained by the fact that patients with essential hypertension
without vascular disease are not available in our material.
On the other hand, the Anglo-American literature [15]
characterizes DBN as focal sclerosing glomerulonephritis
and therefore not as a consequence of hypertension.
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